WIPO trademark

VIASKIN

MixedWIPOClass 5Class 10Class 42

"VIASKIN" is a trademark owned by DBV Technologies, filed at the WIPO on March 13, 2026. It is on file and covers classes 5, 10 and 42.

View DBV Technologies portfolioGet this data via the API
VIASKIN
Trademark as filed with the WIPO
Status
Mixed
Filed
March 13, 2026
Registered
Not yet
Expires
March 13, 2036
Application no.
Not recorded
Registration no.
1925791
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
3 classes
Ownership

Who owns VIASKIN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

DBV Technologies

France

64 trademarks in the portfolioView company

Representative

PAIRAULT Annick AB INITIO

PAIRAULT Annick AB INITIO

Goods and services

What the mark covers

The products and services VIASKIN is filed for, grouped by Nice class.

  • Transdermal patches; skin patches and adhesive skin patches for medical use; transdermal patches and adhesive skin patches for treating, relieving or preventing the development or progression of allergies or immunological disorders; transdermal patches and adhesive skin patches for transdermal administration of pharmaceuticals or medical preparations; epicutaneous patches or swabs for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; adhesive patches or epicutaneous adhesive swabs for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; occlusive patches or epicutaneous occlusive swabs for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders; epicutaneous patches or swabs containing a powdered preparation for medical or pharmaceutical use for treating allergies or immunological disorders; epicutaneous patches or swabs for treating allergies or immunological disorders; epicutaneous patches or pads containing allergens or antigens for treating allergies or immunological disorders; medicines against allergies; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; parts and accessories of the aforesaid goods.

  • Medical devices, apparatus and instruments for cutaneous or epicutaneous administration or delivery, or administration or delivery via a patch, of medical or pharmaceutical substances for the treatment, relief or prevention of allergies or immunological disorders; medical instruments for training, namely, non-medicated skin patches and swabs sold without medication for receiving, maintaining or containing medical or pharmaceutical substances for treatment, relief or prevention of allergies or immunological disorders; medical instruments for training, namely, non-medicated skin patches and swabs sold without medication for use in medical training; medical instruments for training, namely, non-medicated skin patches and swabs for medical use sold without medication, namely, for use in training healthcare professionals on transdermal administration of pharmaceutical products or medical preparations; medical devices, apparatus and instruments sold without medication for the subsequent cutaneous or epicutaneous administration of medical or pharmaceutical substances; dispensers and applicators for swabs, skin patches, and occlusive patches for medical use; parts and accessories of the aforesaid goods.

  • Medical and scientific research services in the field of allergies and immunotherapy; development of scientific methods for cutaneous and epicutaneous immunotherapy; medical and scientific research relating to the treatment, relief and prevention of autoimmune, infectious and inflammatory diseases; medical and scientific research in the fields of allergy treatment and care; allergen drug research services; medical and scientific research services, namely development of methods for treating allergies via contact between allergens and the skin; medical and scientific research services, namely development of methods for treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to the skin of patients; information, advisory and consultancy services relating to the aforementioned services.

FAQ

About VIASKIN

Who owns the trademark "VIASKIN"?

The WIPO trademark "VIASKIN" is owned by DBV Technologies.

What is the status of "VIASKIN"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VIASKIN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_39b843ad-ecd9-4bc2-9535-d7bce7d50ccc
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_39b843ad-ecd9-4bc2-9535-d7bce7d50ccc",
  "object": "trademark",
  "mark_text": "VIASKIN",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2026-03-13",
  "nice_classes": [
    5,
    10,
    42
  ],
  "owners": [
    {
      "name": "DBV TECHNOLOGIES",
      "entity_id": "ent_019eb706-d4df-739e-ba1d-b3581088cd30"
    }
  ]
}